Inovio Pharmaceuticals's total assets for Q1 2026 were $49.78M, a decrease of -33.01% from the previous quarter. INO total liabilities were $43.71M for the fiscal quarter, a -12.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.